Ameritas Investment Partners’s Cytosorbents Corp CTSO Stock Holding History

Ameritas Investment Partners’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,468	Closed	-$11K	–	3101
2022 Q1	$11K	Hold	3,468	–	–	﹤0.01%	2753
2021 Q4	$15K	Hold	3,468	–	–	﹤0.01%	2757
2021 Q3	$28K	Hold	3,468	–	–	﹤0.01%	2505
2021 Q2	$26K	Hold	3,468	–	–	﹤0.01%	2587
2021 Q1	$30K	Buy	3,468 +800	+30%	+$7.63K	﹤0.01%	2374
2020 Q4	$21K	Hold	2,668	–	–	﹤0.01%	2441
2020 Q3	$21K	Hold	2,668	–	–	﹤0.01%	2343
2020 Q2	$26K	Hold	2,668	–	–	﹤0.01%	2201
2020 Q1	$21K	Hold	2,668	–	–	﹤0.01%	2144
2019 Q4	$10K	Hold	2,668	–	–	﹤0.01%	2735
2019 Q3	$13K	Hold	2,668	–	–	﹤0.01%	2607
2019 Q2	$18K	Hold	2,668	–	–	﹤0.01%	2500
2019 Q1	$20K	Hold	2,668	–	–	﹤0.01%	2371
2018 Q4	$22K	Hold	2,668	–	–	﹤0.01%	2280
2018 Q3	$34K	Hold	2,668	–	–	﹤0.01%	2201
2018 Q2	$30K	Buy	+2,668	New	+$25.3K	﹤0.01%	2275

Other funds holding CTSO

Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return

Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameritas Investment Partners's CTSO Position: Q2 2022 in Review

Ameritas Investment Partners sold out of Cytosorbents Corp (CTSO) in Q2 2022, closing a stake of 3,468 shares — an estimated $11K sold.

Ameritas Investment Partners first reported a position in CTSO in Q2 2018 and held it in 16 quarters. The position peaked at $34K in Q3 2018. 78 funds tracked by Wall St. Rank hold CTSO as of Q2 2022.

Ameritas Investment Partners reported no remaining Cytosorbents Corp position as of Q2 2022 after selling out during the quarter.
Ameritas Investment Partners sold 3,468 Cytosorbents Corp shares in Q2 2022, an estimated $11K.
Ameritas Investment Partners first reported a position in Cytosorbents Corp in Q2 2018 and held it in 16 quarters.
Ameritas Investment Partners's Cytosorbents Corp position peaked at $34K in Q3 2018.
78 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2022.

Based on Ameritas Investment Partners's 13F filing for Q2 2022, filed 12 Aug 2022.